C L Duncan
Overview
Explore the profile of C L Duncan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
957
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naik H, Duncan C
J Food Prot
. 2019 Feb;
41(2):100-103.
PMID: 30795180
Thermal inactivation studies of Clostridium perfringens enterotoxin revealed that biological activity was destroyed within 5 min at 60 C, whereas about 10% or less residual serological activity could be detected...
2.
De Azavedo J, Dresser L, Duncan C, Walker S, Low D, Bast D
J Chemother
. 2007 Sep;
19(4):392-7.
PMID: 17855183
Fluoroquinolone-resistance among pneumococci is low; however the number of isolates with a single ParC mutation has increased. Consequently, more potent agents are needed to minimize resistance selection. We investigated the...
3.
Bast D, Dresser L, Duncan C, Walker S, Mandell L, Low D, et al.
J Chemother
. 2007 Feb;
18(6):634-40.
PMID: 17267342
Standard 7-14 day (d) courses of antimicrobial therapy for community-acquired pneumonia (CAP) are thought to have contributed to the emergence of resistant pneumoccoci. Consequently, short-course fluoroquinolone regimens have been proposed...
4.
De Azavedo J, Duncan C, Kilburn L, Downar J, Kong B, Lad S, et al.
J Chemother
. 2006 Oct;
18(4):373-8.
PMID: 17024792
Serial passage of a clinical isolate of Streptococcus pneumoniae, in the presence of moxifloxacin, gatifloxacin or gemifloxacin, gave rise to resistant isolates. Non-susceptibility as defined by Clinical and Laboratory Standards...
5.
Low D, Muller M, Duncan C, Willey B, de Azavedo J, McGeer A, et al.
Antimicrob Agents Chemother
. 2002 Mar;
46(4):1119-21.
PMID: 11897603
The in vitro activity of BMS-284756 against 602 Staphylococcus aureus isolates, including 152 that were both methicillin and ciprofloxacin resistant (MIC > or = 4 microg/ml), was determined. For ciprofloxacin-susceptible...
6.
Bast D, Low D, Duncan C, Kilburn L, Mandell L, Davidson R, et al.
Antimicrob Agents Chemother
. 2000 Oct;
44(11):3049-54.
PMID: 11036021
We report on amino acid substitutions in the quinolone resistance-determining region of type II topisomerases and the prevalence of reserpine-inhibited efflux for 70 clinical isolates of S. pneumoniae for which...
7.
de Azavedo J, Yeung R, Bast D, Duncan C, Borgia S, Low D
Antimicrob Agents Chemother
. 1999 Sep;
43(9):2144-7.
PMID: 10471555
A total of 3,205 group A streptoccal isolates were collected in 1997 through a private laboratory which serves community physicians in southern Ontario and which represents a population base of...
8.
Poppe C, Duncan C, Mazzocco A
Can J Vet Res
. 1998 Jul;
62(3):191-8.
PMID: 9684048
This study determined and compared Salmonella contamination rates of pools of surplus, early and culled hatching eggs from layer and broiler breeder flocks, and of pools of early and regular...
9.
Duncan C, Cummings S, Hudes E, Zahnd E, Coates T
J Gen Intern Med
. 1992 Jul;
7(4):398-404.
PMID: 1506945
Objective: To describe why medical patients quit smoking and the methods they use. Design: Cross-sectional and prospective cohort design. Patient smokers were enrolled in a study of physician counseling about...
10.
Cummings S, Richard R, Duncan C, Hansen B, Vander Martin R, Gerbert B, et al.
J Gen Intern Med
. 1989 Nov;
4(6):482-9.
PMID: 2685206
Study Objective: To test the hypotheses that physicians in private practice who receive a continuing education program (entitled "Quit for Life") about how to counsel smokers to quit would counsel...